Chemoprevention in brain cancer by activation of Nrf2/Keap1/ARE pathway has come up as a very attractive approach, and therapeutic exploitation on this approach can lead to groundbreaking discoveries in the treatment and prevention of brain tumors. The gene discussed is KEAP1; the disease is brain neoplasm.